Abbvie Cuts EPS
Abbvie sees Apogee deal hurting 2026 adjusted EPS by 14c/shr and 2027 adjusted EPS by 46c/shr
Sees Funding Apogee Deal With Debt Sees Apogee Deal Hurting 2027 Adj EPS By 46c/SHR
Abbvie sees Apogee deal hurting 2026 adjusted EPS by 14c/shr and 2027 adjusted EPS by 46c/shr
Sees Funding Apogee Deal With Debt Sees Apogee Deal Hurting 2027 Adj EPS By 46c/SHR